| Net Cash Provided by (Used in) Operating Activities |
$730,988 |
USD |
-16585% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$5,809,985 |
USD |
|
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$3,270,508 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
10,000,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
2,049,621,210 |
shares |
4787% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,808,489 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$1,109,000 |
USD |
21% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,109,000 |
USD |
21% |
Q2 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$10,836 |
USD |
0% |
Q2 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0 |
pure |
|
Q1 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$446,000 |
USD |
|
Q2 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$24,734,958 |
USD |
137% |
Q3 2025 |
Q1 2026 |
| Share-based Payment Arrangement, Expense |
$83,585 |
USD |
-91% |
Q2 2024 |
FY 2024 |
| Interest Expense |
$10,171 |
USD |
-66% |
Q1 2025 |
Q3 2025 |